Spots Global Cancer Trial Database for REMASTer: REcurrent Brain Metastases After SRS Trial
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: REMASTer: REcurrent Brain Metastases After SRS Trial
Official Title: REMASTer: REcurrent Brain Metastases After SRS Trial
Study ID: NCT05124912
Study Description
Brief Summary: Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Duke University Hospital, Durham, North Carolina, United States
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Kettering Health, Kettering, Ohio, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
